Drug-induced Liver Injury - Gibson

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/26

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

27 Terms

1
New cards
  • adverse toxic drug reaction resulting in liver injury

  • Liver is exposed to all substances circulating in the body - prone to injury

  • Over 1,100 meds that are considerate for heaptotoxcity

  • causes 11-13% of all acute liver failures in the US

    • 2000 fulminant cases annually

  • Hepatotoxicity is #1 cause for post-market drug withdrawal

DILI definition

2
New cards

Female

Adults

Alcohol

Malnutrition

Risk factors for DILI

3
New cards

Need

  • Elevated Liver enzymes + Drug culprit

Drug culprit

  • causality established/strongly suspected using a validated tool (RUCAM) or DILI scoring

How to diagnose DILI

4
New cards
  • used to estimate hepatotoxic potential of drugs in trials

  • Sensitive and specific predictor of a drugs potential to cause severe liver injury

  • Patients have >10 % risk of mortality from DILI if TWO OR MORE of following

    • AST/ALT > 3x ULN

    • Totally bili > 2x ULN WITHOUT cholestasis

    • No alternative causes of LFT elevations

    • Some sources add jaundice

What is HY’s Law?

5
New cards

Direct toxicity

  • Acetaminophen, amiodarone, anabolic steroids, valproic acid, statins, HAART

DILI categorization (Intrinsic)

6
New cards

R <2 = Cholestatic

  • Amox/Clav, trimethoprim, azathioprine

R (2-5) = Mixed

  • Fluoroquinolones, macrolides, phenytoin, carbamazepine

R > 5 = Hepatocellular

  • Isoniazid, nitrofurantoin, lamotrigine, PPI’s, TNF-Alpha inhibitors

DILI categorization (Idiosyncratic)

7
New cards

Steatohepatitis

  • AMio, tamoxifen, methotrexate

Neoplastic

  • Anabolic steroids

Vascular

  • Azathioprine

DILI categorization (Other)

8
New cards
  • Dose dependent injury

  • Onset of hours to days

  • Predictable

  • Lipophilic drug characteristics

  • Reactive metabolites - oxidative stress (mechanism)

Intrinsic DILI categorization/symptoms

9
New cards
  • NOT Dose dependent injury

  • Onset of weeks to months

  • Unpredictable

  • Variable mechanism (may be allergic or non-allergy)

  • Based on injury pattern or score

Idiosyncratic DILI categorization/symptoms

10
New cards
  • Damages liver cells

  • Variable reversibility

  • Significant LFT elevations

    • ALT >800 U/L or >20 ULN + Bilirubin elevated

  • R > 5

  • General sx of liver toxicity

  • impacts PT/INR

  • Worse outcomes

Hepatocellular DILI points

11
New cards
  • Damages bile flow

  • Usually reversible

  • AlkPhos > 3x ULN + Bilirubin elevated

  • R <2

  • Pruritis, jaundice, eosinophilia, etc

  • Impacts PT/INR

  • Less Morbid!!!

Cholestatic DILI points

12
New cards

R = (ALT / ALT ULN) / (ALP / ALP ULN)

  • Hepatocellular DILI = R >5

  • Mixed DILI - (R = 2-5)

  • Cholestatic DILI = R <2

Hepatocellular vs Cholestatic DILI - R value interpretations

13
New cards

Discontinue Drug!!!

  • Decisions guided by patient specific factors

  • Spontaneous recovery usually occurs after drug D/C (and confirms it was drug caused)

Main treatment for DILI

14
New cards

Supportive care

  • Hospitalize patients with signs of liver failure

    • Jaundice, encephalopathy, coagulopathy

  • Serial measurement of LFTS for all patients

  • Consider Vit K for coagulopathy

  • Consider Cholestyramine or colestipol for pruritus

Additional DILI treatment

15
New cards

Cholestyramine

If a patient experiences DILI (hepatotoxicity) with Leflunamide OR Terbinafine, what would you give them as therapy?

16
New cards

Carnitine

If a patient experiences DILI (hepatotoxicity) with Valproate, what would you give them as therapy?

17
New cards

Leucovorin

If a patient experiences DILI (hepatotoxicity) with Methotrexate, what would you give them as therapy?

18
New cards

N-Acetylcysteine (NAC)

If a patient experiences DILI (hepatotoxicity) with Acetaminophen , what would you give them as therapy?

19
New cards
  • CANNOT be resumed in FULMINANT disease

  • Med rechallenge should only be considered IF:

    • Drug-induced mechanism is uncertain

    • Great need for the medication

    • Lack of of other treatment options

    • ALl sx have resolved

  • Resume at HALF DOSE

  • Monitor LFTS quickly + often

Points about possible rechallenge of drugs after a DILI

20
New cards

The Glucoronidation and Glutathione conjugation pathways that form the stable metabolites for excretion become OVERSATURATED

  • Cause the covalent binding and oxidative stress that kills hepatocytes

How does Acetaminophen Overdose happen? (pathophys)

21
New cards
  • Most effective when given promptly (within 8-10 hours) after acute ingestion

  • Serves as Glutathione substitute - enhances the non-toxic sulfating conjugation of Tylenol

Easy way: Supplements stable metabolites!!!

How does NAC work and treat Acetaminophen overdose?

22
New cards

Chronic Toxicity of Tylenol

  • Only administer if acetaminophen levels > 20 mcg/mL AND LFT elevations

NAC is ineffective for _____ and should only administer when?

23
New cards
  • Always administer for ingestions > 30 grams

  • Check Tylenol blood levels within 4-24 hours of ingestion for other patients

    • Do not allow lab delays to interfere with treatment

    • Compare levels to Rumack Matthew nomogram

Decision to administer points for NAC

24
New cards
  1. take Tylenol level

  2. plot on Axis

  3. If ABOVE THE SOLID DIAGONAL LINE - Treat with NAC!!!!

Rumack-Matthew Nomogram points

25
New cards

Dosing goal: deliver > 300 mg/kg IV or PO in first 20-24 hours

“Three Bag regimen”

  1. Load: 150 mg/kg (max 15g) IV over 1 hour

  2. Second Dose: 50 mg/kg (max 5g) over 4 hours

  3. Third Dose: 100 mg/kg (max 10g) over 15 hours

  4. Evaluate for stopping criteria

NAC dosing goal + dosing

26
New cards
  1. APAP level <10 mcg/mL

  2. INR < 2

  3. LFTS normal or reduced by 25%-50%

  4. Clinical stability

What are the stopping criteria for NAC? (Must have all of them to stop NAC)

27
New cards
  • Edema

  • Facial flush

  • Skin rash

  • Pruritus

  • Urticaria (hives)

  • Hypersenstivity

  • Vomiting

NAC adverse reactions